ES2033258T3 - Procedimiento para preparar una composicion para sistema terapeuticos transdermales. - Google Patents
Procedimiento para preparar una composicion para sistema terapeuticos transdermales.Info
- Publication number
- ES2033258T3 ES2033258T3 ES198787107310T ES87107310T ES2033258T3 ES 2033258 T3 ES2033258 T3 ES 2033258T3 ES 198787107310 T ES198787107310 T ES 198787107310T ES 87107310 T ES87107310 T ES 87107310T ES 2033258 T3 ES2033258 T3 ES 2033258T3
- Authority
- ES
- Spain
- Prior art keywords
- carbon atoms
- moiety
- composition
- fatty acid
- transdermal therapeutic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000000203 mixture Substances 0.000 title abstract 4
- 230000001225 therapeutic effect Effects 0.000 title abstract 2
- 125000004432 carbon atom Chemical group C* 0.000 abstract 4
- 150000004665 fatty acids Chemical class 0.000 abstract 3
- 150000001733 carboxylic acid esters Chemical class 0.000 abstract 2
- 235000014113 dietary fatty acids Nutrition 0.000 abstract 2
- 229930195729 fatty acid Natural products 0.000 abstract 2
- 239000000194 fatty acid Substances 0.000 abstract 2
- SENZQDBEHBQBNR-UHFFFAOYSA-N 2-(aminomethyl)-4-tert-butyl-6-methylsulfonylphenol Chemical compound CC(C)(C)C1=CC(CN)=C(O)C(S(C)(=O)=O)=C1 SENZQDBEHBQBNR-UHFFFAOYSA-N 0.000 abstract 1
- 239000013543 active substance Substances 0.000 abstract 1
- 125000003158 alcohol group Chemical group 0.000 abstract 1
- 150000001735 carboxylic acids Chemical group 0.000 abstract 1
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 abstract 1
- 229960003883 furosemide Drugs 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 229950005256 lemidosul Drugs 0.000 abstract 1
- 239000002171 loop diuretic Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
- A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
SE DESCRIBE UNA COMPOSICION PARA SISTEMAS TERAPEUTICOS TRANSDERMALES, QUE CONTIENEN COMO SUSTANCIA ACTIVA FUROSEMIDA, PIRETANIDA O LEMIDOSUL, O UNA SAL FISIOLOGICAMENTE TOLERABLE DE ESTOS DIURETICOS CORRECTORES, CONSISTENTES EN UNA ALCANOLAMIDA DE ACIDO GRASO, O UNA MEZCLA DE ALCANOLAMIDAS DE ACIDO GRASO, CON 8-18 ATOMOS DE CARBONO, EN UN RESTO DE ACIDO GRASO, Y 2 A 6 ATOMOS DE CARBONO Y 1 A 3 GRUPOS HIDROXI EN UN RESTO ALCANOLAMIDA Y, DADO EL CASO, UN ETER DE ACIDO CARBOXILICO, O UNA MEZCLA DE UN ESTER DE ACIDO CARBOXILICO, CON PREFERENTEMENTE 1-22 ATOMOS DE CARBONO EN LA PORCION ACIDO CARBOXILICO, Y 1-22 ATOMOS DE CARBONO EN LA PORCION ALCOHOL.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19863617824 DE3617824A1 (de) | 1986-05-27 | 1986-05-27 | Zusammensetzung fuer transdermale therapeutische systeme von schleifendiuretika |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2033258T3 true ES2033258T3 (es) | 1993-03-16 |
Family
ID=6301739
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES198787107310T Expired - Lifetime ES2033258T3 (es) | 1986-05-27 | 1987-05-20 | Procedimiento para preparar una composicion para sistema terapeuticos transdermales. |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP0247507B1 (es) |
| JP (1) | JPS62283936A (es) |
| KR (1) | KR870010872A (es) |
| AT (1) | ATE59782T1 (es) |
| AU (1) | AU7338587A (es) |
| CA (1) | CA1306677C (es) |
| DE (2) | DE3617824A1 (es) |
| DK (1) | DK268287A (es) |
| ES (1) | ES2033258T3 (es) |
| GR (1) | GR3001558T3 (es) |
| IL (1) | IL82639A0 (es) |
| PT (1) | PT84946B (es) |
| ZA (1) | ZA873771B (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3806852A1 (de) * | 1988-03-03 | 1989-09-14 | Knoll Ag | Neue (alpha)-aminodicarbonsaeure-derivate, ihre herstellung und verwendung |
| US5686100A (en) * | 1994-11-22 | 1997-11-11 | E.R. Squibb & Sons, Inc. | Prophylactic and therapeutic treatment of skin sensitization and irritation |
| DE10223932A1 (de) * | 2002-05-29 | 2003-12-18 | Rudolf Wank | Verwendung von Diuretika zur Behandlung von Schwellungen |
| GB0517838D0 (en) * | 2005-09-02 | 2005-10-12 | Henderson Morley Plc | Transdermal active principle delivery means |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3238102A (en) * | 1961-07-14 | 1966-03-01 | Taisho Pharmaceutical Co Ltd | Solubilization of hydrocortisone acetate |
| US3175949A (en) * | 1962-01-08 | 1965-03-30 | Bristol Myers Co | Emulsion of mineral oil, lauric diethanolamide, and water |
| CA1154024A (en) * | 1980-04-17 | 1983-09-20 | Werner Schafer | Transdermal carrier materials |
| DE3025367A1 (de) * | 1980-07-04 | 1982-01-28 | Hoechst Ag, 6000 Frankfurt | Salz aus furosemid oder piretanid als saeurekomponente und penbutolol oder (-)-3-(4- (3-(3,4-dimethoxyphenylaethylamino)-2-hydroxy-propoxy) -phenyl ) -crotonsaeurenitril als basenkomponente, verfahren zu seiner herstellung, dieses enthaltendes mittel und dessen verwendung |
| EP0139127A1 (en) * | 1983-08-22 | 1985-05-02 | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft | Transdermal drug delivery device and its preparation |
| JPS61103840A (ja) * | 1984-10-26 | 1986-05-22 | Nitto Electric Ind Co Ltd | 外皮投与用組成物 |
-
1986
- 1986-05-27 DE DE19863617824 patent/DE3617824A1/de not_active Withdrawn
-
1987
- 1987-05-20 ES ES198787107310T patent/ES2033258T3/es not_active Expired - Lifetime
- 1987-05-20 DE DE8787107310T patent/DE3767212D1/de not_active Expired - Fee Related
- 1987-05-20 AT AT87107310T patent/ATE59782T1/de active
- 1987-05-20 EP EP87107310A patent/EP0247507B1/de not_active Expired - Lifetime
- 1987-05-24 IL IL82639A patent/IL82639A0/xx unknown
- 1987-05-26 AU AU73385/87A patent/AU7338587A/en not_active Abandoned
- 1987-05-26 CA CA000538049A patent/CA1306677C/en not_active Expired - Fee Related
- 1987-05-26 JP JP62127270A patent/JPS62283936A/ja active Pending
- 1987-05-26 PT PT84946A patent/PT84946B/pt unknown
- 1987-05-26 DK DK268287A patent/DK268287A/da unknown
- 1987-05-26 ZA ZA873771A patent/ZA873771B/xx unknown
- 1987-05-27 KR KR870005256A patent/KR870010872A/ko not_active Withdrawn
-
1991
- 1991-03-06 GR GR91400061T patent/GR3001558T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE3767212D1 (de) | 1991-02-14 |
| KR870010872A (ko) | 1987-12-18 |
| DK268287D0 (da) | 1987-05-26 |
| GR3001558T3 (en) | 1992-11-23 |
| DK268287A (da) | 1987-11-28 |
| PT84946A (de) | 1987-06-01 |
| EP0247507B1 (de) | 1991-01-09 |
| ZA873771B (en) | 1987-11-20 |
| PT84946B (de) | 1989-07-21 |
| CA1306677C (en) | 1992-08-25 |
| ATE59782T1 (de) | 1991-01-15 |
| EP0247507A3 (en) | 1988-02-10 |
| JPS62283936A (ja) | 1987-12-09 |
| EP0247507A2 (de) | 1987-12-02 |
| IL82639A0 (en) | 1987-11-30 |
| AU7338587A (en) | 1987-12-03 |
| DE3617824A1 (de) | 1987-12-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2076412T3 (es) | Proceso para la fabricacion de microesferas. | |
| FR2289484A1 (fr) | Esters d'acides cyclopropanecarboxyliques, leur procede de preparation et leur utilisation notamment comme insecticides | |
| CA2009890A1 (en) | Valproic acid | |
| SE8403487D0 (sv) | Farmaceutisk komposition | |
| ATE77547T1 (de) | Pharmazeutische zusammensetzungen mit verlaengerter wirkung und verfahren zu ihrer herstellung. | |
| ES2057064T3 (es) | Preparado farmaceutico para administracion percutanea, que contiene bunazosina o sus sales. | |
| JPS5569586A (en) | 11* 66 and 22substitutedd11carbaa22penenn 33carboxylic acid | |
| YU221889A (en) | Process for producing new pharmaceutical mixture | |
| BG50273A3 (en) | Method for the preparation of esters of the 1- benzyl- 3- hydroxymethylinedazol | |
| YU47192A (sh) | Transdermalni tretirajući sistem sa supstancom kao nosačem za potpomaganje transdermalne penetracije i postupak za njegovo dobijanje | |
| IL82639A0 (en) | Transdermal pharmaceutical composition | |
| ES445489A1 (es) | Procedimiento para la preparacion de nuevos compuestos de macrolida. | |
| US4600583A (en) | Pharmaceutical compositions | |
| ATE2746T1 (de) | Piperidinderivate von 4,5-dialkyl-3-hydroxypyrrol-2-carbons[ureestern, ihre herstellung und diese enthaltende pharmazeutische zubereitungen. | |
| DE68900693D1 (de) | Pharmazeutische praeparate zur transdermalen applikation von heparin. | |
| ES8403123A1 (es) | "procedimiento para la preparacion de esteres del acido alcoxivincaminico". | |
| JPS5640607A (en) | Drug composition | |
| TH3152B (th) | ส่วนผสมสารกระตุ้นเซล | |
| JPS5679626A (en) | Semi-solid medicine | |
| JPS56110614A (en) | External anti-inflammatory and analgesic drug | |
| TR17139A (tr) | 1-kalbalkoksi-2-siyanovinil-(tiyono)fosforik(fosfonik)asid esterleri veya ester amidleri bunlarin hazirlanmasina mahsus usul ve ensektisidler ve akarisidler olarak kullanilmasi | |
| TH2032A (th) | ส่วนผสมสารกระตุ้นเซล | |
| BE771292A (fr) | Nouveaux esters d'acides phosphoriques et phosphoniques et des thiono-acides analogues, leur procede de preparation et leur utilisation comme insecticides et acaricides | |
| JPS6425720A (en) | Percutaneous absorption pharmaceutical |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG2A | Definitive protection |
Ref document number: 247507 Country of ref document: ES |